Company intelligence / Profile preview

QuatreLab

Alès, Occitanie, France

Ownership: Private
Development stage: Other

Overview

QuatreLab is a French joint venture established by Sanofi and LFB (Laboratoire français du Fractionnement et des Biotechnologies) to operate a high-capacity biomanufacturing facility. Located in Alès, France, the company specializes in the industrial-scale production of monoclonal antibodies using advanced cell culture technologies. The partnership was formed to leverage Sanofi's industrial excellence and LFB's expertise in developing innovative biopharmaceuticals. QuatreLab plays a significant role in the European bioproduction supply chain, focusing on the manufacturing of complex biologics for its parent organizations. The facility was designed to meet stringent global regulatory standards for pharmaceutical production.

Modalities: Monoclonal antibodyBiologic
Industry: Contract Manufacturing Organization

Partnerships

SanofiLFB

Beyond the preview

Go deeper on QuatreLab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QuatreLab.

Explore the full profile